<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02648789</url>
  </required_header>
  <id_info>
    <org_study_id>2015-06-009AC</org_study_id>
    <nct_id>NCT02648789</nct_id>
  </id_info>
  <brief_title>Validation of DNA Methylation Biomarkers for Oral Cancer Detection</brief_title>
  <official_title>Validation of DNA Methylation Biomarkers for Oral Cancer Detection</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Taipei Veterans General Hospital, Taiwan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>iStat Biomedical CO., Ltd.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Taipei Veterans General Hospital, Taiwan</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate the correlation between DNA methylation and the
      treatment and recurrence of oral cancer.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this study, investigators plan to recruit 40~50 patients who had, or currently has oral
      cancer. The study procedures are as below:

        -  After the Informed Consent Form is signed, swab from the lesion site and normal site to
           obtain oral epithelial cells.

        -  Collect tissue from the tumor site and the non-cancerous matched site from the surgery
           or the tissue bank.

        -  Collect oral swab from the lesion site and the normal site when patients return to the
           clinic for a regular follow-up.

      Specimens will be collected for DNA methylation testing, and the results will be compared
      with patient's clinical diagnosis. It is expected that the relationship between DNA
      methylation, oral cancer, and the recurrence of oral cancer will be found.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>May 2015</start_date>
  <completion_date type="Anticipated">May 2016</completion_date>
  <primary_completion_date type="Anticipated">May 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Association between the DNA methylation level and the stage of cancer</measure>
    <time_frame>1 year</time_frame>
    <description>Compare the DNA methylation level and the stage of cancer before treatment.
DNA methylation level as a monitor tool for recurrence/metastasis of oral cancer.
qPCR will be used to determine the DNA methylation level.</description>
  </primary_outcome>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Oral Cancer</condition>
  <condition>Recurrence</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      oral swab, non-cancerous matched tissue and tumor tissue
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Investigators plan to retrieve the tissue from the biobank in Taipei Veterans General
        Hospital or recruit oral cancer patients in this study over six months. The total patient
        number are 40-50. Specimen types include non-cancerous matched tissues, cancer tissues, and
        the oral swab. DNA methylation for several genes will be tested by using standardized
        reagents and instruments.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age between 20 and 75 years old

          -  Had or currently has cancer of the oral cavity

          -  Agree to sign the Informed Consent Form (ICF) and comply with follow-up procedures

        Exclusion Criteria:

          -  Unwilling to sign the Informed Consent Form (ICF)

          -  Has an autoimmune disease of the oral cavity
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Cheng-Chieh Yang, DDS., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Stomatology, Taipei Veterans General Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Shou-Yen Kao, DDS., M.D.S.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Stomatology, Taipei Veterans General Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Cheng-Chieh Yang, DDS., Ph.D.</last_name>
    <phone>+886-2-2826-7000</phone>
    <phone_ext>5331</phone_ext>
    <email>ccyang@ym.edu.tw, ccyang13@vghtpe.gov.tw</email>
  </overall_contact>
  <location>
    <facility>
      <name>Taipei Veterans General Hospital</name>
      <address>
        <city>Taipei</city>
        <zip>112</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cheng-Chieh Yang, DDS., Ph.D.</last_name>
      <phone>+886-2-2826-7000</phone>
      <phone_ext>5331</phone_ext>
      <email>ccyang@ym.edu.tw, ccyang13@vghtpe.gov.tw</email>
    </contact>
    <investigator>
      <last_name>Cheng-Chieh Yang, DDS., Ph.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Shou-Yen Kao, DDS., M.D.S.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <reference>
    <citation>Wang SS, Smiraglia DJ, Wu YZ, Ghosh S, Rader JS, Cho KR, Bonfiglio TA, Nayar R, Plass C, Sherman ME. Identification of novel methylation markers in cervical cancer using restriction landmark genomic scanning. Cancer Res. 2008 Apr 1;68(7):2489-97. doi: 10.1158/0008-5472.CAN-07-3194.</citation>
    <PMID>18381458</PMID>
  </reference>
  <reference>
    <citation>Sova P, Feng Q, Geiss G, Wood T, Strauss R, Rudolf V, Lieber A, Kiviat N. Discovery of novel methylation biomarkers in cervical carcinoma by global demethylation and microarray analysis. Cancer Epidemiol Biomarkers Prev. 2006 Jan;15(1):114-23.</citation>
    <PMID>16434596</PMID>
  </reference>
  <reference>
    <citation>Lai HC, Lin YW, Chang CC, Wang HC, Chu TW, Yu MH, Chu TY. Hypermethylation of two consecutive tumor suppressor genes, BLU and RASSF1A, located at 3p21.3 in cervical neoplasias. Gynecol Oncol. 2007 Mar;104(3):629-35. Epub 2006 Nov 13.</citation>
    <PMID>17097722</PMID>
  </reference>
  <reference>
    <citation>Towle R, Garnis C. Methylation-mediated molecular dysregulation in clinical oral malignancy. J Oncol. 2012;2012:170172. doi: 10.1155/2012/170172. Epub 2012 May 7.</citation>
    <PMID>22645611</PMID>
  </reference>
  <reference>
    <citation>García MP, García-García A. Epigenome and DNA methylation in oral squamous cell carcinoma. Methods Mol Biol. 2012;863:207-19. doi: 10.1007/978-1-61779-612-8_12. Review.</citation>
    <PMID>22359295</PMID>
  </reference>
  <reference>
    <citation>Nagata S, Hamada T, Yamada N, Yokoyama S, Kitamoto S, Kanmura Y, Nomura M, Kamikawa Y, Yonezawa S, Sugihara K. Aberrant DNA methylation of tumor-related genes in oral rinse: a noninvasive method for detection of oral squamous cell carcinoma. Cancer. 2012 Sep 1;118(17):4298-308. doi: 10.1002/cncr.27417. Epub 2012 Jan 17.</citation>
    <PMID>22252571</PMID>
  </reference>
  <reference>
    <citation>Fakhry C, Gillison ML. Clinical implications of human papillomavirus in head and neck cancers. J Clin Oncol. 2006 Jun 10;24(17):2606-11. Review.</citation>
    <PMID>16763272</PMID>
  </reference>
  <reference>
    <citation>Chaturvedi AK, Engels EA, Anderson WF, Gillison ML. Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol. 2008 Feb 1;26(4):612-9. doi: 10.1200/JCO.2007.14.1713.</citation>
    <PMID>18235120</PMID>
  </reference>
  <reference>
    <citation>Huang YK, Peng BY, Wu CY, Su CT, Wang HC, Lai HC. DNA methylation of PAX1 as a biomarker for oral squamous cell carcinoma. Clin Oral Investig. 2014 Apr;18(3):801-8. doi: 10.1007/s00784-013-1048-6. Epub 2013 Aug 2.</citation>
    <PMID>23907469</PMID>
  </reference>
  <verification_date>January 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 19, 2015</study_first_submitted>
  <study_first_submitted_qc>January 5, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 7, 2016</study_first_posted>
  <last_update_submitted>January 5, 2016</last_update_submitted>
  <last_update_submitted_qc>January 5, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 7, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Primary oral cancer</keyword>
  <keyword>DNA methylation</keyword>
  <keyword>Recurrence oral cancer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Recurrence</mesh_term>
    <mesh_term>Mouth Neoplasms</mesh_term>
    <mesh_term>Lip Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

